Replies to post #191821 on Biotech Values

[honestabe13]

Vin...

looks like sloan kettering agrees that bavituximab is worthwile after all, even though you said it's useless by itself.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114117455